Get Quote
SPARAZONE-3GM - Cefoperazone & Sulbactam for Injection 3 gm packaging by Suyash Pharma
Authentic packaging of SPARAZONE-3GM by Suyash Pharma
MDR INFECTIONS

SPARAZONE-3GM

Cefoperazone & Sulbactam for Injection 3 gm

SPARAZONE-3GM is an evidence-based formulation following the ICMR 2022 optimal dose approach for multidrug-resistant gram-negative infections, with a nephrofriendly profile requiring no dose adjustment in CKD patients.

Dosage Form Powder for Intravenous Injection or Infusion
Strength 3.0 gm (2 gm Cefoperazone + 1 gm Sulbactam)
Route For I.M. / I.V. Use Only
Packaging Single Dose Sterile Vial (3 gm)
Composition Each vial contains: Cefoperazone Sodium IP equivalent to Cefoperazone 2.0 gm & Sulbactam Sodium IP equivalent to Sulbactam 1.0 gm

Clinical Indications

  • Respiratory tract infections in critical care (pneumonia, bronchitis)
  • Peritonitis, cholecystitis and complicated intra-abdominal infections
  • Complicated urinary tract infections (cUTI)
  • Bacterial septicemia and bacteremic episodes
  • Multidrug-resistant (MDR) pathogen management